Trimurthi Drugs & Pharmaceuticals has informed that the board of directors of the company at its meeting held on September 15, 2012, has considered and approved the allotment of 13,50,000 convertible warrants to the non promoters on preferential basis.
The above information is a part of company's filings submitted to BSE.